Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(50%)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Terminated(2)

Detailed Status

Terminated1
Active, not recruiting1
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated125%
active_not_recruiting125%
withdrawn125%
recruiting125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

NCT07051707
active_not_recruitingnot_applicable

Evaluation of the Safety and Efficacy of TLD in Patients with COPD

NCT03639051
terminatednot_applicable

Evaluating the Safety and Feasibility of TLD for the Treatment of Severe Asthma

NCT02872298
withdrawn

Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD Population

NCT03213080

Clinical Trials (4)

Showing 4 of 4 trials
NCT07051707Not Applicable

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

Recruiting
NCT03639051Not Applicable

Evaluation of the Safety and Efficacy of TLD in Patients with COPD

Active Not Recruiting
NCT02872298Not Applicable

Evaluating the Safety and Feasibility of TLD for the Treatment of Severe Asthma

Terminated
NCT03213080

Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD Population

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4